Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT06604611

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06604611
Other papers using this trial's data
  • Colchicine in acutely decompensated heart failure: the COLICA trial European heart journal, 2024-12-01 DOI, PubMed 39211951, PMC11637759 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06604611. Randomized; no masking; primary purpose treatment. Start 2024-10-31 (anticipated); primary completion 2025-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation
Acronym
CHIPS
Condition
Heart Failure
Condition
Chronic Inflammation
Condition
Inflammation
Condition
Colchicine
Intervention (Drug)
Colchicine 0.5 MG Oral Tablet Once Daily
Lead sponsor
Dongying Zhang (class: other)
Collaborator
National Natural Science Foundation of China (class: other government)

Record details

Record id
cardio:ct-nct06604611
Content hash
2913e426cd4340056df5d98db6cd9b9c7a4874f996d5d8aa6753f9e9f0b81de1